Share
Economic uncertainty has dampened the anticipated digital health M&A momentum for early 2025, but the sector is still far from stagnant. While larger deals and IPOs have largely paused, there have still been smaller, strategic acquisitions continuing to push forward. This signals that investors are recalibrating—not retreating—and using this phase to strengthen fundamentals and focus on value creation.
In
Modern Healthcare's recent article,
Brad Kuntz, Senior Managing Director, discussed how potential acquirers are seeking for clarity on more volatile aspects such as interest rates and the extent to which businesses will be impacted by tariffs.
Read More
Rob Larson was featured by Bezinga, offering his expert insights on the current state of healthcare within PE and why investments continue to be made in the industry, Read more.
Partner Chen Liu attended CivStart's GovTech conference, sharing his insights and key takeaways on what GovTech providers and investors should know. Read more.
Grant Thornton Stax has released its annual Top 20 Ranking of Exhibition Organizers. Click here to explore the full list.
Global Practice Leader Paul Edwards explains how diligence is changing and how confidence and conviction are adding exit value. Read the full article here.
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
Grant Thornton Stax supported Outcomes, a leading provider of clinical network services and pharmacy technology, on its recent acquisition by H.I.G. Capital. Read more.